Prenatal screening for hemoglobinopathies. III. Applicability of the health belief model
- PMID: 1998332
- PMCID: PMC1682984
Prenatal screening for hemoglobinopathies. III. Applicability of the health belief model
Abstract
A comprehensive prenatal hemoglobinopathy screening program in Rochester, NY, has been described in a preceding paper in this issue of the Journal. A woman identified as a carrier may face three decisions. The first is whether to accept the offer of counseling. The second is whether to have her partner tested. If her partner also tests positive, then the third decision is whether to accept the offer of prenatal diagnosis. This report analyzes factors affecting her decision, with special attention being given to factors invoked by the Health Belief Model. Factors predicting that a patient who we identified as a carrier would come for counseling included the following: patient had no prior knowledge that she is a carrier (P less than .001), a gestational age less than 18 wk (P less than .01), and Caucasian race (P less than .05). For sickle cell trait counselees and beta-thalassamia trait counselees, factors found to predict patient's intent to have partner tested were the following: a greater postcounseling knowledge of the disease (P less than .009), a lesser perceived burden of intervention (P less than .011), and belief that the partner is also a carrier (P less than .008). Also for sickle cell trait counselees and beta-thalassemia trait counselees, factors predicting that the partner actually will be tested were the following: living with the partner (P less than .001), gestational age at identification less than or equal to 18 wk (P less than .001), a lesser perceived burden of intervention (P less than .002), and a greater perceived seriousness of the disease (P less than .05).(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Prenatal screening for hemoglobinopathies. II. Evaluation of counseling.Am J Hum Genet. 1991 Mar;48(3):447-51. Am J Hum Genet. 1991. PMID: 1998331 Free PMC article.
-
Prenatal screening for hemoglobinopathies. I. A prospective regional trial.Am J Hum Genet. 1991 Mar;48(3):439-46. Am J Hum Genet. 1991. PMID: 1998330 Free PMC article.
-
Carrier screening for thalassemia and hemoglobinopathies in Canada.J Obstet Gynaecol Can. 2008 Oct;30(10):950-959. doi: 10.1016/S1701-2163(16)32975-9. J Obstet Gynaecol Can. 2008. PMID: 19038079 Review. English, French.
-
Prenatal diagnosis of hemoglobinopathies in Ontario, Canada.Ann N Y Acad Sci. 2005;1054:507-10. doi: 10.1196/annals.1345.052. Ann N Y Acad Sci. 2005. PMID: 16339708
-
Thalassemias and hemoglobinopathies in Turkey.Hemoglobin. 2014;38(5):305-7. doi: 10.3109/03630269.2014.938163. Epub 2014 Jul 17. Hemoglobin. 2014. PMID: 25030194 Review.
Cited by
-
Using qualitative and quantitative strategies to evaluate knowledge and perceptions about sickle cell disease and sickle cell trait.J Natl Med Assoc. 2006 May;98(5):704-10. J Natl Med Assoc. 2006. PMID: 16749645 Free PMC article.
-
Parents' experiences of universal screening for haemoglobin disorders: implications for practice in a new genetics era.Br J Gen Pract. 2008 Mar;58(548):161-8. doi: 10.3399/bjgp08X277276. Br J Gen Pract. 2008. PMID: 18318970 Free PMC article.
-
What Predicts the Use of Genetic Counseling Services After the Birth of a Child with Down Syndrome?J Genet Couns. 2003 Feb;12(1):43-60. doi: 10.1023/A:1021495117739. J Genet Couns. 2003. PMID: 26142383
-
A comparison of two approaches to education about carrier testing for cystic fibrosis.J Genet Couns. 1995 Jun;4(2):97-113. doi: 10.1007/BF01408633. J Genet Couns. 1995. PMID: 24234308
-
Illness representations, self-regulation, and genetic counseling: a theoretical review.J Genet Couns. 2006 Oct;15(5):325-37. doi: 10.1007/s10897-006-9044-5. J Genet Couns. 2006. PMID: 16972194 Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources